ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,866,917 | +11.2% | 732,272 | +2.2% | 0.00% | 0.0% |
Q1 2024 | $9,769,745 | +20.2% | 716,257 | -3.5% | 0.00% | +100.0% |
Q4 2023 | $8,125,645 | +21.8% | 742,068 | +21.8% | 0.00% | 0.0% |
Q3 2023 | $6,670,871 | -21.7% | 609,212 | -5.4% | 0.00% | -50.0% |
Q2 2023 | $8,522,125 | +42.9% | 643,665 | +46.9% | 0.00% | +100.0% |
Q1 2023 | $5,962,663 | -28.4% | 438,109 | +2.7% | 0.00% | -50.0% |
Q4 2022 | $8,329,760 | +127149.6% | 426,511 | +24.1% | 0.00% | 0.0% |
Q3 2022 | $6,546 | -22.7% | 343,601 | -16.4% | 0.00% | 0.0% |
Q2 2022 | $8,468 | -99.9% | 411,071 | +124.5% | 0.00% | +100.0% |
Q1 2022 | $5,893,000 | +7.9% | 183,141 | +56.1% | 0.00% | 0.0% |
Q4 2021 | $5,462,000 | +15.4% | 117,304 | -33.1% | 0.00% | 0.0% |
Q3 2021 | $4,733,000 | +52.2% | 175,284 | +44.5% | 0.00% | 0.0% |
Q2 2021 | $3,110,000 | +36.7% | 121,274 | +82.2% | 0.00% | 0.0% |
Q1 2021 | $2,275,000 | +10.9% | 66,551 | +9.7% | 0.00% | 0.0% |
Q4 2020 | $2,051,000 | +214.6% | 60,659 | +129.5% | 0.00% | – |
Q3 2020 | $652,000 | – | 26,432 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |